Dr. Jerrold S. Canakis, MD

Dr. Canakis practices at TidalHealth Delmarva Endoscopy Center in Berlin, Maryland.

Dr. Canakis' NPI, 1700874179, was assigned on October 11, 2005. Dr. Canakis graduated from Lewis Katz School of Medicine in 1988. Dr. Canakis holds Maryland license D0059594.

Dr. Canakis' primary practice is TidalHealth Delmarva Endoscopy Center, at 11103 Cathage Rd, Berlin, MD 21811. The practice phone is (410) 847-7900.

Dr. Canakis' primary practice is TidalHealth Delmarva Endoscopy Center in Berlin, Maryland. Dr. Canakis is also affiliated with TidalHealth Atlantic. The medical group on file is TidalHealth Cardiovascular Surgery. Dmand AI also links Dr. Canakis to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Canakis practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Canakis' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Canakis is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Canakis' licenses on file in 5 states: Maryland, Delaware, Florida, Pennsylvania and Alabama.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Canakis treats.

CMS data shows 884 Medicare services from Dr. Canakis across 11 procedure codes in 2024, for 748 Medicare patients. Medicare paid $111,336 for them.

CMS counts 748 Medicare patients who saw Dr. Canakis in 2024. The largest group is 65 to 74, with 452 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Canakis' median patient age at 61, with 58% women.

In 2024, Dr. Canakis wrote 313 Medicare Part D claims for 237 patients. 59% of them were for generic drugs. CMS names the drug for 195 of them, across 7 drugs with 11 or more claims each, at $21,939 in total drug cost. In 2023, CMS named 205 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Canakis for performance year 2024, reported as part of a group. Dr. Canakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Canakis as offering telehealth. CMS counts 198 procedures of colonoscopy by Dr. Canakis, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Canakis in 2024. Dr. Canakis' most frequent co-authors are Jay Amol Bapaye, MD and Charles Melbern Wilcox, MD.

CMS Open Payments shows 789 general payments to Dr. Canakis from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $4,888.

Dmand AI lists 1 award for Dr. Canakis, most recently CMS Stage 1 2012 in 2011.

Dr. Canakis graduated from Lewis Katz School of Medicine in 1988.

Dr. Canakis is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.